SCANTILY PAD- acne treatment liquid

SCANTILY PAD by

Drug Labeling and Warnings

SCANTILY PAD by is a Otc medication manufactured, distributed, or labeled by Dermala Inc. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Salicylic acid 1% ...........Acne Treatment

PURPOSE

For the treatment of ACNE

WARNINGS

WARNINGS For external use only. Skin
irritation and dryness is more likely to
occur when using this product if you use
another topical acne medication at the
same time. If irritation occurs, only use
one topical acne medication at a time.

INDICATIONS & USAGE

For the treatment of Acne

INACTIVE INGREDIENT

INACTIVE INGREDIENTS Organic Aloe vera, organic
grain alcohol, cocamidopropyl dimethylamine, SE
Microbiome ComplexTM, sodium hydroxide, organic
lemon essential oil.

DOSAGE & ADMINISTRATION

DIRECTIONS Cleanse the skin. Use one pad to apply a
thin layer of solution to affected areas. Start with one
application daily, then increase to two times per day
(morning and evening). If dryness or peeling occurs,
reduce application to once a day or every other day.
Test on a small area of skin before applying to face. If
eye contact occurs, flush thoroughly with water.

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

SCANTILY PAD 
acne treatment liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 81953-100
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	0.01 mg  in 1 mg

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)	0.8 mg  in 1 mg

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 81953-100-01	50 mg in 1 JAR; Type 0: Not a Combination Product	06/01/2021

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	06/01/2021

Labeler - Dermala Inc (079278092)